Clinical Trials Directory

Trials / Completed

CompletedNCT01172431

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
240 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
65 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effects of indapamide SR 1.5 mg on renal function, endothelial function, blood pressure variability by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension.

Conditions

Interventions

TypeNameDescription
DRUGIndapamideIndapamide SR 1.5mg qd
DRUGHydrochlorothiazideHydrochlorothiazide 25mg qd

Timeline

Start date
2010-09-01
Primary completion
2012-03-01
Completion
2013-12-01
First posted
2010-07-29
Last updated
2014-06-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01172431. Inclusion in this directory is not an endorsement.